(Date:11/23/2009)...um computing promises ultra-fast communication, co...ive information. But trying to use quantum states ...e business. Now two physicists have shown, mathema... quantum communication, while keeping the informat...issue of Physical Review Letters and highlighted...
(Date:11/23/2009)... MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBio...roductdevelopmentcompanythatidentifiesandadvancesa...tvariousstagesofdevelopment,todayreportedthatCytop...evaluatingCYT387,apotent,orally-administeredJAK1/J...nRochester,Minnesota.AproposaltomergeCytopiaintoYM...
(Date:11/23/2009)... SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or p.(I...CasExecutiveChairman.Dr.Carterhasasuccessfultrackr...f or merChiefExecutiveOfficeratZymoGenetics,inSeat...enhagen,Denmark. ,, (Photo: http://www.newscom....nReed,IDC,sfounderandChiefExecutiveOfficercommente...
(Date:11/23/2009)... REDWOODCITY,Calif.,Nov.23/PRNewswire/--PearlThera...rapeuticproductsforthetreatmentofchronicrespirator...tothecompany,sBoardofDirectors.Mr.Rosenhas25yearso...stries,includingkeyrolesatGileadSciencesandALZACor...rsonPearl,sBoardtosix. ,, "Howiebringsawealthof...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2